BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 7, 2026
Home » Topics » Medical devices » Digital health

Digital health
Digital health RSS Feed RSS

Steadying hand while reaching for glass

New screening tool locks on to Parkinson’s disease psychosis

Sep. 14, 2020
By David Godkin
TORONTO – Most doctors recognize the symptoms instantly: hand tremors, slurred speech, impaired posture and balance. What they don’t always associate with people suffering from Parkinson’s disease are hallucinations and delusions.
Read More
Ribbons of digital data

Biopharma companies utilizing artificial intelligence for drug research

Sep. 14, 2020
By Peter Winter
The BioWorld Artificial Intelligence price-weighted index, which includes biopharmaceutical companies, medical devices and health care services companies, has climbed in value and is currently up almost 37% year-to-date.
Read More
Silhouettes

Click Therapeutics, Boehringer Ingelheim partner on digital therapeutic for schizophrenia

Sep. 11, 2020
By Annette Boyle
Click Therapeutics Inc. and Boehringer Ingelheim GmbH inked a deal valued at more than $500 million to collaborate on the development and commercialization of a prescription-based digital therapeutic for schizophrenia. The mobile application, currently called CT-155, uses cognitive and neurobehavioral techniques to reduce the symptoms of schizophrenia, such as cognitive deficits and impaired social functioning.
Read More

Regulatory actions for Sept. 11, 2020

Sep. 11, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avinger, Cardio-Phoenix.
Read More
VR headset on child in hospital bed

Oncomfort creates cushion for growth with €10M series A fundraising

Sep. 10, 2020
By Annette Boyle
Oncomfort SA finalized a €10 million (US$11.8 million) series A fundraising round to further develop its Digital Sedation product and pursue international expansion. Debiopharm and Crédit Mutuel Innovation led the round with participation from Wallonia Innovation and Growth and previous investors.
Read More
Software screenshot on laptop, computer monitor

RapidAI debuts Rapid Web App, wins ISO 27001 certification

Sep. 10, 2020
By Meg Bryant
RapidAI, which focuses on imaging for stroke, has launched the Rapid Web App to help stroke teams stay updated on imaging results and communicate securely. Using the app, team members can receive real-time browser notifications of new cases, preview Rapid results and source files and engage in workflow communications via a desktop or laptop computer.
Read More
Handshake dollar sign

Radiology Partners scoops up Mednax Radiology Solutions for $885M

Sep. 10, 2020
By Liz Hollis
Mednax Inc. has inked a definitive agreement through which Radiology Partners will acquire the former's radiology solutions group for $885 million, with an eye toward creating a provider of comprehensive radiology and teleradiology services. El Segundo, Calif.-based Radiology Partners is a physician-owned, on-site radiology practice that partners with about 1,600 radiologists providing services to nearly 1,300 hospitals, clinics and imaging centers across 26 states. When the transaction wraps up, the combined organization, operated under the Radiology Partners name, will include more than 2,400 radiology physicians who provide services in every state plus Washington.
Read More
Diagram illustration

Lifetime Initiative provides roadmap to transformation of European health care through interceptive medicine

Sep. 9, 2020
By Annette Boyle
The Lifetime Initiative released a roadmap to revolutionize health care in Europe by implementing cell-based interceptive medicine in a perspective article published Sept. 7 in Nature.
Read More

Other news to note for Sept. 9, 2020

Sep. 9, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambu, Analog Devices, A.R.C. Laser, Avricore Health, Benchmark Electronics, Change Healthcare, Clearside Biomedical, Coracoid Solutions, Coremap, D&D Pharmatech, Dnanudge, Evonetix, Fotona, Genova Diagnostics, Gogomeds, Hospitec, Joint Commission, Kit Check, Lifelabs, Livongo, Lncbio, Magellan Health, Medline Industries, Nanostring, Nanox, Orexo, Paradise Genomics, Parvizi Surgical Innovation, Personal Genome Diagnostics, Pharmigene, Regenexbio, Respiration, Rocky Mountain Analytical, S2 Genomics, Sca Pharma, Scrum, Spi Medical, Sqi Diagnostics, Thermo Fisher Scientific, Thrive Health, Thunderbio Science, Trendbio, Vizient.
Read More

In the clinic for Sept. 9, 2020

Sep. 9, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alydia Health, BD, Dreamed Diabetes, Sight Sciences.
Read More
Previous 1 2 … 93 94 95 96 97 98 99 100 101 … 134 135 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 6, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 6, 2026.
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing